ATE412735T1 - Verfahren zur reinigung von zellen - Google Patents

Verfahren zur reinigung von zellen

Info

Publication number
ATE412735T1
ATE412735T1 AT02774007T AT02774007T ATE412735T1 AT E412735 T1 ATE412735 T1 AT E412735T1 AT 02774007 T AT02774007 T AT 02774007T AT 02774007 T AT02774007 T AT 02774007T AT E412735 T1 ATE412735 T1 AT E412735T1
Authority
AT
Austria
Prior art keywords
nscs
present
cells
precursor cells
molecules
Prior art date
Application number
AT02774007T
Other languages
English (en)
Inventor
Perry Bartlett
Rodney Rietze
Original Assignee
Univ Queensland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Queensland filed Critical Univ Queensland
Application granted granted Critical
Publication of ATE412735T1 publication Critical patent/ATE412735T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT02774007T 2001-06-01 2002-05-31 Verfahren zur reinigung von zellen ATE412735T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR5403A AUPR540301A0 (en) 2001-06-01 2001-06-01 A method of purification of cells

Publications (1)

Publication Number Publication Date
ATE412735T1 true ATE412735T1 (de) 2008-11-15

Family

ID=3829381

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02774007T ATE412735T1 (de) 2001-06-01 2002-05-31 Verfahren zur reinigung von zellen

Country Status (9)

Country Link
US (1) US7435586B2 (de)
EP (1) EP1402005B1 (de)
JP (3) JP5027376B2 (de)
AT (1) ATE412735T1 (de)
AU (2) AUPR540301A0 (de)
CA (1) CA2449979C (de)
DE (1) DE60229636D1 (de)
NZ (1) NZ529896A (de)
WO (1) WO2002097067A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2467781C (en) * 2000-11-20 2014-09-23 Canadian Blood Services Use of a monoclonal antibody specific for a red blood cell to inhibit the reticuloendothelial system for the treatment of thrombocytopenia
WO2006113731A2 (en) * 2005-04-20 2006-10-26 University Of Florida Research Foundation, Inc. Bone marrow-derived neurogenic cells and uses thereof
WO2008048671A1 (en) 2006-10-18 2008-04-24 University Of Illinois Embryonic-like stem cells derived from adult human peripheral blood and methods of use
US9388382B2 (en) 2005-10-05 2016-07-12 The Board Of Trustees Of The University Of Illinois Isolation of CD14 negative, CD45 positive and CD117 positive embryonic-like stem cells free of monocytes from human umbilical cord blood mononuclear cells
US8309343B2 (en) 2008-12-01 2012-11-13 Baxter International Inc. Apparatus and method for processing biological material
PT105083A (pt) * 2009-04-28 2011-07-25 Univ De Coimbra Processo para cultura de células estaminais neurais baseado nas ampacinas e/ou outros moduladores de receptores glutamatérgicos ionotrópicos, composições e seu uso em condições do sistema nervoso central
US8895291B2 (en) 2010-10-08 2014-11-25 Terumo Bct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
US9790468B2 (en) * 2013-03-15 2017-10-17 Avita Iinternational Ltd. Multifunctional immature dental pulp stem cells and therapeutic applications
JP6612227B2 (ja) 2013-11-16 2019-11-27 テルモ ビーシーティー、インコーポレーテッド バイオリアクターにおける細胞増殖
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
WO2016049421A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
WO2017205667A1 (en) 2016-05-25 2017-11-30 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
WO2018184028A2 (en) 2017-03-31 2018-10-04 Terumo Bct, Inc. Cell expansion
TW202013385A (zh) * 2018-06-07 2020-04-01 美商河谷控股Ｉｐ有限責任公司 基於差異的基因組之辨識分數
GB2619893A (en) 2021-03-23 2023-12-20 Terumo Bct Inc Cell capture and expansion
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU780256B2 (en) 1999-02-12 2005-03-10 Boco Silicon Valley, Inc. Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
US20030003572A1 (en) 1999-03-05 2003-01-02 David J. Anderson Isolation and enrichment of neural stem cells from uncultured tissue based on cell-surface marker expression
US20030040119A1 (en) * 2001-04-11 2003-02-27 The Regents Of The University Of Michigan Separation devices and methods for separating particles

Also Published As

Publication number Publication date
EP1402005A4 (de) 2006-02-22
JP2004532041A (ja) 2004-10-21
AU2002308446B2 (en) 2007-08-23
NZ529896A (en) 2005-02-25
US7435586B2 (en) 2008-10-14
EP1402005A1 (de) 2004-03-31
JP2009077725A (ja) 2009-04-16
JP5027376B2 (ja) 2012-09-19
AUPR540301A0 (en) 2001-06-28
EP1402005B1 (de) 2008-10-29
JP2012120545A (ja) 2012-06-28
WO2002097067A1 (en) 2002-12-05
US20040235158A1 (en) 2004-11-25
CA2449979C (en) 2015-11-24
CA2449979A1 (en) 2002-12-05
DE60229636D1 (de) 2008-12-11

Similar Documents

Publication Publication Date Title
DE60229636D1 (de) Verfahren zur reinigung von zellen
Ng et al. Human long non-coding RNAs promote pluripotency and neuronal differentiation by association with chromatin modifiers and transcription factors
Guan et al. Chemical reprogramming of human somatic cells to pluripotent stem cells
Hsieh Orchestrating transcriptional control of adult neurogenesis
Ming et al. Adult neurogenesis in the mammalian brain: significant answers and significant questions
Sun et al. Epigenetic regulation of neurogenesis in the adult mammalian brain
Lampe et al. Effect of macromer weight percent on neural cell growth in 2D and 3D nondegradable PEG hydrogel culture
Shu et al. Single-cell RNA sequencing reveals Nestin+ active neural stem cells outside the central canal after spinal cord injury
Steindler et al. Astrocytes as stem cells: nomenclature, phenotype, and translation
Cheung et al. X-chromosome inactivation in rett syndrome human induced pluripotent stem cells
Banfi et al. SETBP1 accumulation induces P53 inhibition and genotoxic stress in neural progenitors underlying neurodegeneration in Schinzel-Giedion syndrome
US12577530B2 (en) Generation of a population of hindbrain cells and hindbrain-like organoids from pluripotent stem cells
Smagin et al. Aberrant expression of collagen gene family in the brain regions of male mice with behavioral psychopathologies induced by chronic agonistic interactions
Khazeem et al. TOP2B is required to maintain the adrenergic neural phenotype and for ATRA-induced differentiation of SH-SY5Y neuroblastoma cells
Abramova et al. Stage-specific changes in gene expression in acutely isolated mouse CNS progenitor cells
Nestor et al. Human inducible pluripotent stem cells and autism spectrum disorder: emerging technologies
Sagner et al. Temporal patterning of the central nervous system by a shared transcription factor code
Hezroni et al. Regulation of neuronal commitment in mouse embryonic stem cells by the Reno1/Bahcc1 locus
Luciani et al. Human iPSC-derived neural stem cells displaying radial glia signature exhibit long-term safety in mice
Farley et al. Shaking up the silence: consequences of HMGN1 antagonizing PRC2 in the Down syndrome brain
Shi et al. Signatures of altered DNA methylation gene expression after central and peripheral nerve injury
CN111979194A (zh) 重编程细胞的方法
Lim et al. Understanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patients
Mätlik et al. Histone bivalency in CNS development
JP2005526015A5 (de)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties